|
業務類別
|
-- |
|
業務概覽
|
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue. |
| 公司地址
| Darwinweg 24, Leiden, ZH, NLD, 2333 CR |
| 電話號碼
| +31 715247400 |
| 傳真號碼
| +31 715247445 |
| 公司網頁
| https://www.pharming.com |
| 員工數量
| 409 |
| Mr. Fabrice Chouraqui, M.B.A.,Pharm.D. |
Executive Director and Chief Executive Officer |
-- |
02/04/2026 |
| Mr. Kenneth Lynard |
Chief Financial Officer |
-- |
02/04/2026 |
| Dr. Alexander Breidenbach, PhD |
Chief Business Officer |
-- |
02/04/2026 |
| Mr. Ruud van Outersterp |
Chief Legal and Compliance Officer |
-- |
02/04/2026 |
| Dr. Anurag Relan, M.D. |
Chief Medical Officer |
-- |
02/04/2026 |
| Ms. Mireille Sanders, M. Sc. |
Chief Operations Officer |
-- |
02/04/2026 |
| Ms. Ines Bernal |
Chief People Officer |
-- |
02/04/2026 |
| Mr. Leverne Marsh |
Chief Commercial Officer |
-- |
02/04/2026 |
| Ms. Maryana Reurings-Tsiganko |
Vice President, Strategy & Operations |
-- |
02/04/2026 |
|
|
| Dr. Elaine Sullivan, PhD |
Independent Director |
02/04/2026 |
| Mr. Fabrice Chouraqui, M.B.A.,Pharm.D. |
Executive Director and Chief Executive Officer |
02/04/2026 |
| Dr. Richard Peters, M.D.,PhD |
Chairman of the Board |
02/04/2026 |
| Dr. Mark J. Pykett,PhD,V.M.D. |
Vice Chairman of the Board |
02/04/2026 |
| Ms. Jabine van der Meijs |
Independent Director |
02/04/2026 |
| Mr. Leonard Kruimer |
Independent Director |
02/04/2026 |
| Ms. Barbara Yanni |
Director |
02/04/2026 |
|
|
|
|
